Bone rarefaction and crush fractures in juvenile chronic arthritis.
Główni autorzy: | Elsasser, U, Wilkins, B, Hesp, R, Thurnham, D, Reeve, J, Ansell, B |
---|---|
Format: | Journal article |
Wydane: |
1982
|
Podobne zapisy
-
Deflazacort in juvenile chronic arthritis.
od: Loftus, J, i wsp.
Wydane: (1993) -
Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids.
od: Reeve, J, i wsp.
Wydane: (1993) -
Spinal and somatic growth in patients with juvenile chronic arthritis treated for up to 2 years with deflazacort.
od: David, J, i wsp.
Wydane: (1992) -
Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
od: Rooney, M, i wsp.
Wydane: (2000) -
Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
od: Loftus, J, i wsp.
Wydane: (1991)